A Study of Visilizumab in Subjects With Intravenous Steroid-Refractory Ulcerative Colitis

Clinical trial NCT00279422 · TERMINATED

Trial details

NCT number: NCT00279422
Sponsor: Facet Biotech
Status: TERMINATED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Ulcerative Colitis

Start date: 2006-02-01
Primary completion: 2007-08-01
Enrollment: 127

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.